Vantage Consulting Group’s Sanofi SNY Stock Holding History

Vantage Consulting Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-91	Closed	-$4K	–	1345
2020 Q4	$4K	Buy	+91	New	+$4.49K	﹤0.01%	1514

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Vantage Consulting Group's SNY Position: Q1 2021 in Review

Vantage Consulting Group sold out of Sanofi (SNY) in Q1 2021, closing a stake of 91 shares — an estimated $4K sold.

Vantage Consulting Group first reported a position in SNY in Q4 2020 and held it in 1 quarter. The position peaked at $4K in Q4 2020. 572 funds tracked by Wall St. Rank hold SNY as of Q1 2021.

Vantage Consulting Group reported no remaining Sanofi position as of Q1 2021 after selling out during the quarter.
Vantage Consulting Group sold 91 Sanofi shares in Q1 2021, an estimated $4K.
Vantage Consulting Group first reported a position in Sanofi in Q4 2020 and held it in 1 quarter.
Vantage Consulting Group's Sanofi position peaked at $4K in Q4 2020.
572 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.